Monday was an eventful day in the stock markets and one of the stocks that went on a remarkable run yesterday was that of Ibio Inc (NYSEAMERICAN:IBIO). The stock has made significant gains this year so far but has pulled back over 7% since Friday.
That being said, it is necessary to keep in mind that there was no material news regarding the company’s business on Monday. However, there has been plenty of positive news in the past and there is the belief that a positive trigger could be coming for the iBio stock soon.
The company is involved in developing vaccines for COVID 19 and at this point in time, it has two candidates in the pipeline. In addition to that, it should be noted that the two candidates being developed by iBio will only need a single dose. The same cannot be said of many of the other candidates that are being developed.
Lastly, iBio owns the FastPharming Facility that will allow it to develop these vaccines quickly and gives it a certain edge over its peers. While these may have been encouraging signs, investors have been getting anxious since iBio has not provided any updates regarding the development of these vaccines in recent days.
First of all, it needs to be remembered that the development of such a vaccine is going to take time, however, it is believed that an update regarding the matter may not be far away. In an upcoming update, iBio is going to provide the preclinical data from the testing of its second vaccine candidate and the latest on the first candidate as well. If any of these two updates prove to be positive in nature, then it could prove to be a huge trigger for the iBio stock. Hence, investors need to perhaps keep their eyes peeled over the coming days. Sign up below to receive critical updates on IBIO and other fast-moving small cap stocks.